We offer virtual consultation to help patients whose physical limitations make travel to the clinic impossible
The search for a pill formulation of insulin has been long-standing. Yesterday Novo Nordisk, the world’s biggest insulin manufacturer abandoned its efforts to make an oral form of insulin. The obstacle was not technological it was price pressure.
The pharmaceutical industry has figured out how to protect insulin from digestive juices in the stomach – the question is can it be done cost-effectively? Novo says no, Oramed.com continues to research its its own oral insulin.
For more information see http://www.reuters.com/article/idUSKBN13B22I